Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

VOR

Vor Biopharma Inc

Dec 11 • 04:00PM ET

0.9798

Dollar change -0.0302
Percentage change -2.99	%

Healthcare • Biotechnology • USA • NASD

Peers: BMY GILD MRNA REGN VRTX BLUE CRSP EDIT NTLA PFE

| Held by: VTI VXF CNCR IWC CHNA DFAC RFLR

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.65	Insider Own	12.86%	Shs Outstand	68.66M	Perf Week	9.56%
Market Cap	67.29M	Forward P/E	-	EPS next Y	-1.19	Insider Trans	0.00%	Shs Float	59.84M	Perf Month	-2.99%
Income	-112.46M	PEG	-	EPS next Q	-0.33	Inst Own	58.87%	Short Float	2.36%	Perf Quarter	-6.69%
Sales	0.00M	P/S	-	EPS this Y	11.12%	Inst Trans	-26.08%	Short Ratio	2.42	Perf Half Y	-22.24%
Book/sh	1.06	P/B	0.92	EPS next Y	23.62%	ROA	-66.35%	Short Interest	1.41M	Perf Year	-49.88%
Cash/sh	0.91	P/C	1.07	EPS next 5Y	-	ROE	-90.79%	52W Range	0.63 - 3.14	Perf YTD	-56.45%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-73.43%	ROI	-110.64%	52W High	-68.80%	Beta	-0.40
Dividend TTM	-	Quick Ratio	4.69	Sales past 5Y	0.00%	Gross Margin	-	52W Low	55.52%	ATR (14)	0.09
Dividend Ex-Date	-	Current Ratio	4.69	EPS Y/Y TTM	12.32%	Oper. Margin	-	RSI (14)	60.38	Volatility	14.65% 9.96%
Employees	168	Debt/Eq	0.45	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.12	Target Price	13.21
Option/Short	Yes / Yes	LT Debt/Eq	0.39	EPS Q/Q	18.01%	Payout	-	Rel Volume	1.10	Prev Close	1.01
Sales Surprise	-	EPS Surprise	0.55%	Sales Q/Q	-	Earnings	Nov 07 AMC	Avg Volume	584.14K	Price	0.98
SMA20	13.59%	SMA50	23.60%	SMA200	-20.50%	Trades		Volume	642,341	Change	-2.99%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-26-22	Initiated	Wedbush	Outperform	$18
Apr-27-22	Initiated	Goldman	Neutral	$6
Dec-17-21	Initiated	H.C. Wainwright	Buy	$26
Dec-03-21	Initiated	Robert W. Baird	Outperform	$38
Dec-02-21	Initiated	Oppenheimer	Outperform	$30
Oct-19-21	Initiated	JMP Securities	Mkt Outperform	$40
Mar-25-21	Initiated	B. Riley Securities	Buy	$60
Mar-03-21	Initiated	Evercore ISI	Outperform	$48
Mar-03-21	Initiated	Barclays	Overweight	$56
Mar-02-21	Initiated	Stifel	Buy	$58
Mar-02-21	Initiated	Goldman	Sell	$19

Show Previous Ratings

Dec-09-24 07:30AM	Vor Bio Provides Clinical Update Further Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies; Receives Supportive Feedback from FDA Regarding Registrational Trial Design (GlobeNewswire) +26.89%
Nov-12-24 08:00AM	Vor Bio to Participate in the Stifel 2024 Healthcare Conference (GlobeNewswire)
Nov-07-24 04:05PM	Vor Bio Reports Third Quarter 2024 Financial Results and Provides Company Update (GlobeNewswire) +14.85%
Sep-30-24 07:00AM	Vor Bio Appoints Seasoned Healthcare Institutional Investor, Han Choi, M.D., LL.M., as Chief Financial Officer (GlobeNewswire)
Sep-06-24 02:00AM	PureTech Founded Entity Vor Bio Announces New Clinical Data Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies (Business Wire) +10.06%
04:01PM	Loading…
Sep-05-24 04:01PM	New Clinical Data Validates Vor Bio's Approach of Using Shielded Transplants to Deliver Targeted Therapies (GlobeNewswire)
Aug-28-24 08:00AM	Vor Bio to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-08-24 04:05PM	Vor Bio Reports Second Quarter 2024 Financial Results and Provides Company Update (GlobeNewswire)
Aug-02-24 04:01PM	Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -7.98% -7.51%
Jul-09-24 04:01PM	Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jun-04-24 04:01PM	Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -7.69%
May-13-24 09:22AM	Oppenheimer Adjusts Vor Biopharma Price Target to $10 From $15, Maintains Outperform Rating (MT Newswires)
May-09-24 10:54PM	VOR Stock Earnings: Vor Biopharma Beats EPS for Q1 2024 (InvestorPlace) -5.52%
04:05PM	Vor Bio Reports First Quarter 2024 Financial Results and Provides Company Update (GlobeNewswire)
May-06-24 08:00AM	Vor Bio to Participate in Upcoming Investor Conferences (GlobeNewswire)
04:01PM	Loading…
May-03-24 04:01PM	Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
May-02-24 04:01PM	Vor Bio Appoints Accomplished Oncology and Cancer Immunotherapy R&D Executive, Fouad Namouni, M.D., to its Board of Directors (GlobeNewswire)
Apr-04-24 08:32AM	Why You Shouldn't Bet Against Vor Biopharma (VOR) Stock (Zacks)
Apr-01-24 08:00AM	Vor Bio to Participate in Upcoming Investor Conferences (GlobeNewswire) -7.17%
Mar-20-24 09:53PM	VOR Stock Earnings: Vor Biopharma Beats EPS for Q4 2023 (InvestorPlace) +8.89%
04:05PM	Vor Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update (GlobeNewswire)
Mar-05-24 04:01PM	Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Mar-04-24 08:00AM	Vor Bio to Participate in Upcoming Investor Conferences (GlobeNewswire)
Feb-15-24 02:56PM	2 Strong Buy Penny Stocks That Could Rally All the Way to $10 (or More) (TipRanks)
Feb-07-24 08:00AM	Vor Bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference (GlobeNewswire)
Feb-02-24 04:01PM	Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -5.53%
Jan-19-24 08:22AM	Vor Bio (VOR) Up on Positive Update From AML Cell Therapy Study (Zacks) -8.30%
Jan-17-24 04:01PM	Vor Bio Doses First AML Patient with VCAR33 (ALLO) and Provides Corporate Update (GlobeNewswire) +7.39%
Dec-21-23 04:01PM	Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -6.11% -8.37%
Dec-01-23 04:01PM	Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +11.98%
08:00AM	Loading…
Nov-27-23 08:00AM	Vor Bio to Participate in the JMP Securities Hematology and Oncology Summit (GlobeNewswire)
Nov-09-23 04:01PM	Vor Bio Presents Positive Data Update on Trem-cel at HSCT Conference (GlobeNewswire) -5.38%
Nov-07-23 04:05PM	Vor Bio Reports Third Quarter 2023 Financial Results and Provides Company Update (GlobeNewswire) +9.34% -6.53%
Nov-03-23 04:01PM	Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +7.43%
08:00AM	Vor Bio to Participate in Upcoming Investor Conferences (GlobeNewswire)
Nov-02-23 09:01AM	Multiple Clinical and Preclinical Presentations at ASH 2023 Highlight Vor Bio's Novel eHSC and CAR-T Platform (GlobeNewswire) +5.74%
Oct-03-23 04:01PM	Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +5.63%
Sep-25-23 08:00AM	Vor Bio to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-30-23 08:00AM	Vor Bio to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-10-23 04:05PM	Vor Bio Reports Second Quarter 2023 Financial Results and Provides Company Update (GlobeNewswire) +14.40%
Aug-01-23 08:00AM	Vor Bio to Participate in the Wedbush PacGrow Healthcare Conference (GlobeNewswire)
Jun-09-23 04:03PM	Vor Bio's Trem-cel Shows Early Encouraging Data In Leukemia Patients (Benzinga) -6.19%
07:30AM	Successful Primary Engraftment of Trem-cel in First Five AML Patients Demonstrates Promise of Vor Bios Platform (GlobeNewswire)
Jun-05-23 08:00AM	Vor Bio to Participate in the Goldman Sachs Healthcare Conference (GlobeNewswire)
May-11-23 04:05PM	Vor Bio Reports First Quarter 2023 Financial Results and Provides Company Update (GlobeNewswire)
Apr-19-23 02:42PM	We Think Vor Biopharma (NASDAQ:VOR) Can Afford To Drive Business Growth (Simply Wall St.)
Apr-18-23 08:00AM	Vor Bio to Participate in Upcoming Investor Conferences (GlobeNewswire) -7.82%
Mar-28-23 09:55AM	How Much Upside is Left in Vor Biopharma Inc. (VOR)? Wall Street Analysts Think 172.06% (Zacks)
Mar-23-23 04:01PM	Vor Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Company Update (GlobeNewswire) -6.08% +15.29%
Mar-07-23 05:52AM	Vor Biopharma Inc. (NASDAQ:VOR) Shares Could Be 43% Below Their Intrinsic Value Estimate (Simply Wall St.)
Feb-21-23 08:00AM	Vor Bio to Participate in Upcoming Investor Conferences (GlobeNewswire)
Feb-16-23 02:04PM	Vor Biopharma's Leukemia Cell Exhibits Favorable Engraftment Five Months Post-Transplant (Benzinga) -6.47%
12:00PM	First AML Patient Transplanted with Vor Bios Trem-cel Demonstrated Durable Engraftment through Multiple Mylotarg Cycles at Initial Dose Level (GlobeNewswire)
Jan-19-23 08:00AM	Vor Bio to Present Clinical Data from First Patient Treated with Trem-cel at 2023 Tandem Meetings (GlobeNewswire)
Jan-12-23 08:00AM	Vor Bio to Present at B. Riley Securities 3rd Annual Oncology Conference (GlobeNewswire)
Dec-16-22 06:40PM	Bath & Body Works and Vor Biopharma Stock See Action From Activist Investors (Barrons.com) -11.17%
Dec-07-22 07:45AM	Vor Bio Prices Underwritten Offering of Common Stock and Concurrent Private Placement for Aggregate Proceeds of $115.8 Million (GlobeNewswire) +41.86%
07:30AM	First AML Patient Successfully Transplanted with Vor Bios Investigational Trem-cel (VOR33) and Tolerated Mylotarg (GlobeNewswire)
Nov-30-22 10:35AM	2 Strong Buy Penny Stocks That Could Rally All the Way to $15 (TipRanks) +6.48%
Nov-22-22 08:00AM	Vor Bio to Participate in Upcoming Investor Conferences (GlobeNewswire)
Nov-10-22 04:15PM	Vor Bio Reports Third Quarter 2022 Financial Results and Provides Company Update (GlobeNewswire) +5.03%
Nov-01-22 08:00AM	Vor Bio to Participate in Upcoming Investor Conferences (GlobeNewswire)
Oct-14-22 10:26AM	Will Vor Biopharma (NASDAQ:VOR) Spend Its Cash Wisely? (Simply Wall St.)
Oct-12-22 08:00AM	Vor Bio Appoints Eyal C. Attar, M.D. as Chief Medical Officer (GlobeNewswire)
Oct-11-22 08:00AM	Vor Bio Demonstrates Potential of Base and Sequential Multiplex Editing of Hematopoietic Stem Cells for Next-generation AML Treatment (GlobeNewswire)
Sep-28-22 08:00AM	Vor Bio Initiates In-house Clinical Manufacturing at Cambridge, MA Headquarters (GlobeNewswire)
Sep-06-22 04:15PM	Vor Bio to Participate in Upcoming Investor Conferences (GlobeNewswire)
Sep-01-22 09:55AM	Can Vor Biopharma Inc. (VOR) Climb 298% to Reach the Level Wall Street Analysts Expect? (Zacks)
Aug-16-22 09:55AM	How Much Upside is Left in Vor Biopharma Inc. (VOR)? Wall Street Analysts Think 295% (Zacks)
Aug-11-22 04:15PM	Vor Bio Reports Second Quarter 2022 Financial Results and Provides Company Update (GlobeNewswire) +8.43%
Aug-01-22 08:00AM	Vor Bio to Participate in Upcoming Investor Conferences (GlobeNewswire) +5.64%
Jun-10-22 08:00AM	Vor Bio Successfully Demonstrates Multiplex Editing of Hematopoietic Stem Cells for Next-generation AML Treatment Presented at EHA (GlobeNewswire)
Jun-01-22 08:00AM	Vor Bio to Participate in Upcoming Investor Conferences (GlobeNewswire)
May-12-22 04:15PM	Vor Bio Reports First Quarter 2022 Financial Results and Provides Company Update (GlobeNewswire)
May-07-22 09:20AM	We Think Vor Biopharma (NASDAQ:VOR) Can Afford To Drive Business Growth (Simply Wall St.)
May-05-22 08:00AM	Vor to Participate in Two Upcoming Investor Conferences (GlobeNewswire)
Apr-25-22 08:00AM	Vor Bio to Present at Keystone Symposia Precision Genome Engineering Meeting (GlobeNewswire)
Apr-14-22 04:15PM	Vor Bio Announces Retirement of Chief Medical Officer (GlobeNewswire) +8.74%
Mar-22-22 10:10AM	Akron BioProducts and Vor Bio to Collaborate on the Development and cGMP Manufacture of Nucleases (Business Wire) +6.16%
Mar-14-22 04:30PM	Vor Bio Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Company Update (GlobeNewswire) -9.52%
Feb-28-22 08:00AM	Vor to Participate in Three Upcoming Investor Conferences (GlobeNewswire)
Feb-11-22 08:00AM	Vor to Participate in the 11th Annual SVB Leerink Global Healthcare Conference (GlobeNewswire) -7.03%
Jan-04-22 08:00AM	Vor to Participate in Two Upcoming Investor Conferences (GlobeNewswire)
Nov-29-21 08:00AM	Vor to Participate in the JMP Securities Hematology and Oncology Summit (GlobeNewswire)
Nov-25-21 07:35AM	15 Pharmaceutical Stocks to Buy According to Peter Kolchinskys RA Capital (Insider Monkey)
Nov-19-21 04:01PM	Vor to Participate in Piper Sandler 33rd Virtual Annual Healthcare Conference (GlobeNewswire) -8.17%
11:48AM	Vor Biopharma Insider Sold Over $5.0M In Company Stock (Benzinga)
Nov-15-21 10:39AM	Does Vor Biopharma (VOR) Have the Potential to Rally 186% as Wall Street Analysts Expect? (Zacks)
Nov-11-21 12:51PM	We're Hopeful That Vor Biopharma (NASDAQ:VOR) Will Use Its Cash Wisely (Simply Wall St.)
Nov-10-21 04:10PM	Vor Reports Third Quarter 2021 Financial Results and Provides Company Update (GlobeNewswire) -6.20%
Nov-09-21 08:30AM	Vor to Present New Data on its Cell and Genome Engineering Platform at SITC Annual Meeting (GlobeNewswire) -5.16%
Nov-08-21 08:00AM	Vor to Participate in Two Upcoming Investor Conferences (GlobeNewswire)
Nov-04-21 09:15AM	Vor to Present New Platform and Preclinical Data at ASH (GlobeNewswire)
Oct-19-21 07:00AM	Vor to Present Data from its Novel Cell and Genome Engineering Platform at ESGCT (GlobeNewswire) +8.27%
Oct-12-21 08:00AM	Vor Strengthens Leadership Team with Addition of Dr. Veit Schmelmer as SVP of Program and Alliance Management (GlobeNewswire)
Sep-09-21 08:00AM	VOR33 Granted U.S. FDA Fast Track Designation for AML (GlobeNewswire)
Sep-02-21 08:00AM	Vor to Participate in Three Upcoming Investor Conferences (GlobeNewswire) +9.51%
Aug-09-21 04:05PM	Vor Reports Second Quarter 2021 Financial Results and Provides Company Update (GlobeNewswire) -7.17%
Jul-08-21 08:00AM	Vor Biopharma Announces Collaboration with Janssen to Develop Engineered Hematopoietic Stem Cell Transplants Combined With a Bi-Specific Antibody Therapy for Acute Myeloid Leukemia (AML) (GlobeNewswire) +9.04%
Jun-17-21 08:00AM	Vor to Build-Out State-of-the-Art Clinical Manufacturing Facility Capable of Supporting Multiple Cell Therapy Programs (GlobeNewswire)

Vor Biopharma, Inc. engages in developing cell therapies for treating cancer. It is a clinical-stage cell therapy company that combines a novel patient engineering approach with therapies to provide a single company solution for patients suffering from hematological malignancies. The company was founded by Aleks Radovic-Moreno and Siddhartha Mukherjee on December 30, 2015 and is headquartered in Cambridge, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Attar Eyal C.	CHIEF MEDICAL OFFICER	Jun 03 '24	Sale	1.39	14,645	20,357	96,063	Jun 04 06:09 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

VOR

Vor Biopharma Inc

Upgrade your FINVIZ experience